The Anti-erbB3 Antibody MM-121/SAR256212 in Combination With Trastuzumab Exerts Potent Antitumor Activity Against Trastuzumab-Resistant Breast Cancer Cells

Molecular Cancer- United Kingdom

doi 10.1186/1476-4598-12-134

Full Text

Abstract

Available in

Date

Authors

Publisher

Springer Science and Business Media LLC


Related search